Trp53 deficiency protects against acute intestinal inflammation

Journal of Immunology

Volumn 191, Issue 2, 2013, Pages 837-847

  Spehlmann, Martina E ^a,c   Manthey, Carolin F ^a,e   Dann, Sara M ^a,f   Hanson, Elaine ^a   Sandhu, Sukhman S ^a   Liu, Linus Y ^a   Abdelmalak, Farid K ^a   Diamanti, Michaela A ^b   Retzlaff, Kristin ^b   Scheller, Jürgen ^c,g   Rose John, Stefan ^c   Greten, Florian R ^b   Wang, Jean Y J ^d   Eckmann, Lars ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF KIEL   (Germany)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF HAMBURG   (Germany)

^f UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^g HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; FAS ANTIGEN; HEAT SHOCK PROTEIN 70; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 22; INTERLEUKIN 6; PROTEIN BCL XL; PROTEIN P53; PUMA PROTEIN; RECOMBINANT INTERLEUKIN 6; STAT3 PROTEIN;

ACUTE DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATM GENE; CELL PROTECTION; CELL SURVIVAL; COLITIS; COLON ULCER; CONTROLLED STUDY; DNA REPAIR; FAS1 GENE; GENE; ICAM1 GENE; INFLAMMATION; INTESTINE EPITHELIUM CELL; LAMINA PROPRIA; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PUMA GENE; TUMOR SUPPRESSOR GENE;

ANIMALS; APOPTOSIS; BONE MARROW CELLS; CELL CYCLE PROTEINS; CELLS, CULTURED; COLITIS; DENDRITIC CELLS; DNA REPAIR; DNA-BINDING PROTEINS; ENZYME ACTIVATION; EPITHELIAL CELLS; INFLAMMATION; INTERLEUKIN-6; INTERLEUKINS; INTESTINAL MUCOSA; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NF-KAPPA B; OXIDATIVE STRESS; PROTEIN-SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 84880085172     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1201716     Document Type: Article

References (59)

1. Collavin,L., A. Lunardi, and G. Del Sal. 2010. p53-family proteins and their regulators: hubs and spokes in tumor suppression. Cell Death Differ. 17: 901-911.
2. Levine, A. J. 1997. p53, the cellular gatekeeper for growth and division. Cell 88: 323-331. (Pubitemid 27131374)
3. Wang,L., Q. Wu, P. Qiu, A. Mirza, M. McGuirk, P. Kirschmeier, J. R. Greene, Y. Wang, C. B. Pickett, and S. Liu. 2001. Analyses of p53 target genes in the human genome by bioinformatic and microarray approaches. J. Biol. Chem. 276: 43604-43610.
4. Wang,B., Z. Xiao, H. L. Ko, and E. C. Ren. 2010. The p53 response element and transcriptional repression. Cell Cycle 9: 870-879.
5. Yeung,S. J., J. Pan, and M. H. Lee. 2008. Roles of p53, MYC and HIF-1 in regulating glycolysis-the seventh hallmark of cancer. Cell. Mol. Life Sci. 65: 3981-3999.
6. Kawauchi,K., K. Araki, K. Tobiume, and N. Tanaka. 2009. Loss of p53 enhances catalytic activity of IKKbeta through O-linked beta-N-acetyl glucosamine modification. Proc. Natl. Acad. Sci. USA 106: 3431-3436.
7. Liu,G., Y. J. Park, Y. Tsuruta, E. Lorne, and E. Abraham. 2009. p53 Attenuates lipopolysaccharide-induced NF-kappaB activation and acute lung injury. J. Immunol. 182: 5063-5071.
8. Yamanishi, Y., D. L. Boyle, M. J. Pinkoski, A. Mahboubi, T. Lin, Z. Han, N. J. Zvaifler, D. R. Green, and G. S. Firestein. 2002. Regulation of joint destruction and inflammation by p53 in collagen-induced arthritis. Am. J. Pathol. 160: 123-130. (Pubitemid 34052273)
9. Simelyte, E., S. Rosengren, D. L. Boyle, M. Corr, D. R. Green, and G. S. Firestein. 2005. Regulation of arthritis by p53: critical role of adaptive immunity. Arthritis Rheum. 52: 1876-1884. (Pubitemid 40852897)
10. Sun,Y., X. R. Zeng, L. Wenger, G. S. Firestein, and H. S. Cheung. 2004. P53 down-regulates matrix metalloproteinase-1 by targeting the communications between AP-1 and the basal transcription complex. J. Cell. Biochem. 92: 258-269.
11. Okuda, Y., M. Okuda, and C. C. Bernard. 2003. Regulatory role of p53 in experimental autoimmune encephalomyelitis. J. Neuroimmunol. 135: 29-37. (Pubitemid 36170148)
12. Nagata,J., H. Kijima, A. Takagi, M. Ito, K. Goto, H. Yamazaki, M. Nakamura, T. Mine, and Y. Ueyama. 2004. Helicobacter pylori induces chronic active gastritis in p53-knockout mice. Int. J. Mol. Med. 13: 773-777.
13. Fujii, S., T. Fujimori, H. Kawamata, J. Takeda, K. Kitajima, F. Omotehara, T. Kaihara, T. Kusaka, K. Ichikawa, Y. Ohkura, et al. 2004. Development of colonic neoplasia in p53 deficient mice with experimental colitis induced by dextran sulphate sodium. Gut 53: 710-716. (Pubitemid 38561450)
14. Greten, F. R., L. Eckmann, T. F. Greten, J. M. Park, Z. W. Li, L. J. Egan, M. F. Kagnoff, and M. Karin. 2004. IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 118: 285-296. (Pubitemid 39061110)
15. Mitsuhashi, J., T. Mikami, K. Saigenji, and I. Okayasu. 2005. Significant correlation of morphological remodeling in ulcerative colitis with disease duration and between elevated p53 and p21 expression in rectal mucosa and neoplastic development. Pathol. Int. 55: 113-121. (Pubitemid 40477222)
16. Brentnall, T. A., D. A. Crispin, P. S. Rabinovitch, R. C. Haggitt, C. E. Rubin, A. C. Stevens, and G. C. Burmer. 1994. Mutations in the p53 gene: an early marker of neoplastic progression in ulcerative colitis. Gastroenterology 107: 369-378. (Pubitemid 24233310)
17. Hussain, S. P., P. Amstad, K. Raja, S. Ambs, M. Nagashima, W. P. Bennett, P. G. Shields, A. J. Ham, J. A. Swenberg, A. J. Marrogi, and C. C. Harris. 2000. Increased p53 mutation load in noncancerous colon tissue from ulcerative colitis: a cancer-prone chronic inflammatory disease. Cancer Res. 60: 3333-3337. (Pubitemid 30482141)
18. Xu, Y., T. Ashley, E. E. Brainerd, R. T. Bronson, M. S. Meyn, and D. Baltimore. 1996. Targeted disruption of ATM leads to growth retardation, chromosomal fragmentation during meiosis, immune defects, and thymic lymphoma. Genes Dev. 10: 2411-2422. (Pubitemid 26341877)
19. Edelmann, W., P. E. Cohen, M. Kane, K. Lau, B. Morrow, S. Bennett, A. Umar, T. Kunkel, G. Cattoretti, R. Chaganti, et al. 1996. Meiotic pachytene arrest in MLH1-deficient mice. Cell 85: 1125-1134. (Pubitemid 26231177)
20. Smits,R., N. Hofland, W. Edelmann, M. Geugien, S. Jagmohan-Changur, C. Albuquerque, C. Breukel, R. Kucherlapati, M. F. Kielman, and R. Fodde. 2000. Somatic Apc mutations are selected upon their capacity to inactivate the beta-catenin downregulating activity. Genes Chromosomes Cancer 29: 229-239.
21. Jonkers, J., R. Meuwissen, H. van der Gulden, H. Peterse, M. van der Valk, and A. Berns. 2001. Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer. Nat. Genet. 29: 418-425. (Pubitemid 34326692)
22. Madison, B. B., L. Dunbar, X. T. Qiao, K. Braunstein, E. Braunstein, and D. L. Gumucio. 2002. Cis elements of the villin gene control expression in restricted domains of the vertical (crypt) and horizontal (duodenum, cecum) axes of the intestine. J. Biol. Chem. 277: 33275-33283. (Pubitemid 34984848)
23. Clausen, B. E., C. Burkhardt, W. Reith, R. Renkawitz, and I. Förster. 1999. Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res. 8: 265-277. (Pubitemid 29523965)
24. Grivennikov,S., E. Karin, J. Terzic, D. Mucida, G. Y. Yu, S. Vallabhapurapu, J. Scheller, S. Rose-John, H. Cheroutre, L. Eckmann, and M. Karin. 2009. IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell 15: 103-113.
25. Katakura, K., J. Lee, D. Rachmilewitz, G. Li, L. Eckmann, and E. Raz. 2005. Toll-like receptor 9-induced type I IFN protects mice from experimental colitis. J. Clin. Invest. 115: 695-702. (Pubitemid 40322244)
26. Dann,S. M., M. E. Spehlmann, D. C. Hammond, M. Iimura, K. Hase, L. J. Choi, E. Hanson, and L. Eckmann. 2008. IL-6-dependent mucosal protection prevents establishment of a microbial niche for attaching/effacing lesion-forming enteric bacterial pathogens. J. Immunol. 180: 6816-6826.
27. van Dam, M., J. Müllberg, H. Schooltink, T. Stoyan, J. P. Brakenhoff, L. Graeve, P. C. Heinrich, and S. Rose-John. 1993. Structure-function analysis of interleukin-6 utilizing human/murine chimeric molecules. Involvement of two separate domains in receptor binding. J. Biol. Chem. 268: 15285-15290. (Pubitemid 23206686)
28. Jostock, T., J. Müllberg, S. Ozbek, R. Atreya, G. Blinn, N. Voltz, M. Fischer, M. F. Neurath, and S. Rose-John. 2001. Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses. Eur. J. Biochem. 268: 160-167. (Pubitemid 32052260)
29. Atreya, R., J. Mudter, S. Finotto, J. Müllberg, T. Jostock, S. Wirtz, M. Schütz, B. Bartsch, M. Holtmann, C. Becker, et al. 2000. Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in crohn disease and experimental colitis in vivo. Nat. Med. 6: 583-588. (Pubitemid 30305911)
30. Heremans,H., C. Dillen, W. Put, J. Van Damme, and A. Billiau. 1992. Protective effect of anti-interleukin (IL)-6 antibody against endotoxin, associated with paradoxically increased IL-6 levels. Eur. J. Immunol. 22: 2395-2401.
31. Hofseth, L. J., S. Saito, S. P. Hussain, M. G. Espey, K. M. Miranda, Y. Araki, C. Jhappan, Y. Higashimoto, P. He, S. P. Linke, et al. 2003. Nitric oxide-induced cellular stress and p53 activation in chronic inflammation. Proc. Natl. Acad. Sci. USA 100: 143-148. (Pubitemid 36078042)
32. Bancroft, L. K., J. R. Lupton, L. A. Davidson, S. S. Taddeo, M. E. Murphy, R. J. Carroll, and R. S. Chapkin. 2003. Dietary fish oil reduces oxidative DNA damage in rat colonocytes. Free Radic. Biol. Med. 35: 149-159. (Pubitemid 36835915)
33. Suzuki, K., K. Inageda, G. Nishitai, and M. Matsuoka. 2007. Phosphorylation of p53 at serine 15 in A549 pulmonary epithelial cells exposed to vanadate: involvement of ATM pathway. Toxicol. Appl. Pharmacol. 220: 83-91. (Pubitemid 46427868)
34. Ma, L., J. Wagner, J. J. Rice, W. Hu, A. J. Levine, and G. A. Stolovitzky. 2005. A plausible model for the digital response of p53 to DNA damage. Proc. Natl. Acad. Sci. USA 102: 14266-14271. (Pubitemid 41429687)
35. Kuerbitz,S. J., B. S. Plunkett, W. V. Walsh, and M. B. Kastan. 1992. Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc. Natl. Acad. Sci. USA 89: 7491-7495.
36. Wu, X., and A. J. Levine. 1994. p53 and E2F-1 cooperate to mediate apoptosis. Proc. Natl. Acad. Sci. USA 91: 3602-3606. (Pubitemid 24139478)
37. Inagaki-Ohara, K., S. Yada, N. Takamura, M. Reaves, X. Yu, E. Liu, I. Rooney, S. Nicholas, A. Castro, C. F. Ware, et al. 2001. p53-dependent radiation-induced crypt intestinal epithelial cells apoptosis is mediated in part through TNFTNFR1 system. Oncogene 20: 812-818. (Pubitemid 32198174)
38. Eckmann,L., T. Nebelsiek, A. A. Fingerle, S. M. Dann, J. Mages, R. Lang, S. Robine, M. F. Kagnoff, R. M. Schmid, M. Karin, et al. 2008. Opposing functions of IKKbeta during acute and chronic intestinal inflammation. Proc. Natl. Acad. Sci. USA 105: 15058-15063.
39. Pickert,G., C. Neufert, M. Leppkes, Y. Zheng, N. Wittkopf, M. Warntjen, H. A. Lehr, S. Hirth, B. Weigmann, S. Wirtz, et al. 2009. STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing. J. Exp. Med. 206: 1465-1472.
40. Ropeleski, M. J., J. Tang, M. M. Walsh-Reitz, M. W. Musch, and E. B. Chang. 2003. Interleukin-11-induced heat shock protein 25 confers intestinal epithelialspecific cytoprotection from oxidant stress. Gastroenterology 124: 1358-1368. (Pubitemid 36531810)
41. Forrester, K., S. Ambs, S. E. Lupold, R. B. Kapust, E. A. Spillare, W. C. Weinberg, E. Felley-Bosco, X. W. Wang, D. A. Geller, E. Tzeng, et al. 1996. Nitric oxide-induced p53 accumulation and regulation of inducible nitric oxide synthase expression by wild-type p53. Proc. Natl. Acad. Sci. USA 93: 2442-2447. (Pubitemid 26104369)
42. Rachmilewitz,D., F. Karmeli, E. Okon, and M. Bursztyn. 1995. Experimental colitis is ameliorated by inhibition of nitric oxide synthase activity. Gut 37: 247-255.
43. Nakaya, N., S. W. Lowe, Y. Taya, A. Chenchik, and G. Enikolopov. 2000. Specific pattern of p53 phosphorylation during nitric oxide-induced cell cycle arrest. Oncogene 19: 6369-6375. (Pubitemid 32641851)
44. Pravda, J. 2005. Radical induction theory of ulcerative colitis. World J. Gastroenterol. 11: 2371-2384. (Pubitemid 40667968)
45. Westbrook,A. M., and R. H. Schiestl. 2010. Atm-deficient mice exhibit increased sensitivity to dextran sulfate sodium-induced colitis characterized by elevated DNA damage and persistent immune activation. Cancer Res. 70: 1875-1884.
46. Keimling,M., and L. Wiesmüller. 2009. DNA double-strand break repair activities in mammary epithelial cells - influence of endogenous p53 variants. Carcinogenesis 30: 1260-1268.
47. Strasser,A., P. J. Jost, and S. Nagata. 2009. The many roles of FAS receptor signaling in the immune system. Immunity 30: 180-192.
48. Sayani, F. A., C. M. Keenan, M. D. Van Sickle, K. R. Amundson, E. J. Parr, R. D. Mathison, W. K. MacNaughton, J. E. Braun, and K. A. Sharkey. 2004. The expression and role of Fas ligand in intestinal inflammation. Neurogastroenterol. Motil. 16: 61-74. (Pubitemid 38253523)
49. Shao,L., Y. Sun, Z. Zhang, W. Feng, Y. Gao, Z. Cai, Z. Z. Wang, A. T. Look, and W. S. Wu. 2010. Deletion of proapoptotic Puma selectively protects hematopoietic stem and progenitor cells against high-dose radiation. Blood 115: 4707-4714.
50. Santhanam, U., A. Ray, and P. B. Sehgal. 1991. Repression of the interleukin 6 gene promoter by p53 and the retinoblastoma susceptibility gene product. Proc. Natl. Acad. Sci. USA 88: 7605-7609. (Pubitemid 21915202)
51. Kawauchi,K., K. Araki, K. Tobiume, and N. Tanaka. 2008. Activated p53 induces NF-kappaB DNA binding but suppresses its transcriptional activation. Biochem. Biophys. Res. Commun. 372: 137-141.
52. Neurath, M. F., S. Pettersson, K. H. Meyer zum Büschenfelde, and W. Strober. 1996. Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-kappa B abrogates established experimental colitis in mice. Nat. Med. 2: 998-1004. (Pubitemid 26306838)
53. Shishodia,S., and B. B. Aggarwal. 2002. Nuclear factor-kappaB activation: a question of life or death. J. Biochem. Mol. Biol. 35: 28-40.
54. González-Navajas,J. M., J. Law, K. P. Nguyen, M. Bhargava, M. P. Corr, N. Varki, L. Eckmann, H. M. Hoffman, J. Lee, and E. Raz. 2010. Interleukin 1 receptor signaling regulates DUBA expression and facilitates Toll-like receptor 9-driven antiinflammatory cytokine production. J. Exp. Med. 207: 2799-2807.
55. Tanaka, K., T. Namba, Y. Arai, M. Fujimoto, H. Adachi, G. Sobue, K. Takeuchi, A. Nakai, and T. Mizushima. 2007. Genetic evidence for a protective role for heat shock factor 1 and heat shock protein 70 against colitis. J. Biol. Chem. 282: 23240-23252. (Pubitemid 47311960)
56. Zenewicz,L. A., G. D. Yancopoulos, D. M. Valenzuela, A. J. Murphy, S. Stevens, and R. A. Flavell. 2008. Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease. Immunity 29: 947-957.
57. Tebbutt, N. C., A. S. Giraud, M. Inglese, B. Jenkins, P. Waring, F. J. Clay, S. Malki, B. M. Alderman, D. Grail, F. Hollande, et al. 2002. Reciprocal regulation of gastrointestinal homeostasis by SHP2 and STAT-mediated trefoil gene activation in gp130 mutant mice. Nat. Med. 8: 1089-1097. (Pubitemid 35175963)
58. Matsumoto,S., T. Hara, K. Mitsuyama, M. Yamamoto, O. Tsuruta, M. Sata, J. Scheller, S. Rose-John, S. Kado, and T. Takada. 2010. Essential roles of IL-6 trans-signaling in colonic epithelial cells, induced by the IL-6/soluble-IL-6 receptor derived from lamina propria macrophages, on the development of colitisassociated premalignant cancer in a murine model. J. Immunol. 184: 1543-1551.
59. Ding,C., and G. Jones. 2006. Anti-interleukin-6 receptor antibody treatment in inflammatory autoimmune diseases. Rev. Recent Clin. Trials 1: 193-200.